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Abstract
Bone constantly cycles through a dynamic process of breakdown and
remodeling. Osteoblasts are the specialized mesenchymal stem cells that have
a major role in bone formation and the remodeling process whereas their
counterpart osteoclasts, handle bone resorption. Embryonic stem cells can be
partially differentiated into Progenitor cells, and we worked with #18, a
candidate for being an osteoprogenitor that has the potential to respond to
morphogenic activators. In the case of bone remodeling, TGF-β 2, BMP-2 and
an abundance of CA++ have been shown to be potential activators of
differentiation into osteoblasts. Eight different trials were conducted with the
cells using different combinations of the three morphogenic activators. After
inducing the cells with the activators, we performed Immunohistochemistry
(IHC) to analyze the expression of osteocalcin, which is the enzyme that binds
calcium to mineralize bone. The cells with varying activator combinations
showed different physiology with a variance in the cell shape, structure, and
spacing. The greatest results were from the combination of TGF-β 2 and
BMP-2, which is consistent with #18 operating as an osteoprogenitor. A 3D
construct model of #18 seemed to have a similar structure to that of an osteon,
possibly indicating the formation of bone. We took slices of the model and
performed an IHC staining for Osteocalcin, Prolyl Hydroxylase (5B5), and
Collagen I. We saw a strong positive signal for Col I and 5B5, and a slight
positive signal for Osteocalcin. This information confirmed that #18 is an
osteoprogenitor and is able to assemble bone.
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Introduction
Human embryonic stem cells (hESC) are primordial, unspecialized
cells that can differentiate into any other cell type. BioTime’s business
is to direct these hESC into progenitor cell lines with the potential to
become differentiated into a variety of different cell types. One of
Biotime’s cell lines, progenitor # 18, is a Mesenchymal stem cell (MSC)
line. Specialized MSC’s can be potentially differentiated into muscle,
tendons, ligaments, fat, and bone. MSC’s are sensitive to the timing of
growth factor presentation and differentiation can be specialized
toward osteoprogenitors responsible for bone formation and
remodeling. We encompassed our research around the question of
whether Progenitor #18 cells have the potential to be differentiated into
primary bone cells called osteoblasts. Osteoblasts distinguish
themselves from other mesenchymal cells through the production of
osteocalcin, which is responsible for the calcification of bone. This
research could advance efforts in the field of bone repair.

Results
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Figure 1: Changing morphology in response to morphogenic activators in #18 (40x)
P60 plate of line #18 in the presence of morphological activators resulted in clear morphological changes. (A) The
control line shows the normal morphology of line #18. (B) Cells induced with BMP-2 began to spread out and
become confluent. (C) Cells induced with TGF-β 2 began to cluster more after induction. (D) The cells treated with a
combination of BMP-2 and TGF-β 2 presented as larger aggregates.

Figure 2: Collagen Expressed in 3D Model (40X)
After taking slices of the 3D model, immunohistochemistry was
performed to characterize the expression of Collagen I. (A) The DAPI
stain presents expression of Collagen I (B) Collagen I does not
completely overlap the nuclei signaling that collagen is made in the
vicinity of the cells.

Figure 5: Embryonic Stem
Cell (ESC) Differentiation to
Bone Cells
Our collaborator “BioTime inc”
took ESCs and derived
Mesenchymal Stem Cells
(MSC) #18. We tested to see
if these cells could be
manipulated into becoming
bone cells (osteoblasts) by
adding BMP-2 and TGFB-2.
We saw Collagen 1 and
Osteocalcin in IHC which
indicates positive bone cell
formation.
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Conclusions
Figure 3: Osteocalcin Expressed in 3D Model (40X)
After taking slices of the 3D model, immunohistochemistry was
performed to characterize the expression of Osteocalcin. (A) The DAPI
stain expresses a positive expression for Osteocalcin. (B) IHC shows
Osteocalcin does not completely overlap with the nuclei and is secreting
osteoid beyond the boundaries of the cell, forming bone.

Materials and Methods
Cell Culture
• A P-60 culture of Human embryonic Progenitor line # 18 was used from BioTime.
• The culture was grown in DMEM 10 % FBS medium and treated to a 5ml PBS followed by Trypsin.
• After centrifugation cell line was divided evenly into an 8 well slide each individual well was
exposed to a combination of three morphogenic activators: BMP-2 (10 uL), TGF-β2 (10 uL), and Ca
++ (2.5 uL)
• After 4 days of incubation images were taken for morphology and culture was returned to 37° C
incubator
Cell Culture Immunohistochemistry (IHC)
• 7 days after adding morphogenic activators, IHC was conducted.
• Cell were separated, marked by pap-pen and fixed to slide using Acetone methanol solution for 10
minutes at room temperature.
• Cells were stained for 50 minutes with a 1:200 dilution of primary antibodies, Osteocalcin and
Collagen I
• A second antibody was used at a 1:200 dilution of goat antimouse IgG 594 Red.
• Cell culture was examined by conventional fluorescent microscope (Axiovert 40 CFL) with images
taken from Nikon D600
3D Construct Immunohistochemistry (IHC)
• 3D model, created by the progenitor line, was sectioned by a cryostat
• Slices were taken and placed on glass slides to be observed with a microscope
• Two different slides were divided up and stained for 50 minutes.
• Slide 1 was stained with Osteocalcin
• Slide 2 was stained with Collagen I
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• Human Embryonic Stem Cells can be partially differentiated
into progenitor cell lines. We chose #18 as a candidate for
the formation of osteoblasts.
• We tested factors that trigger Osteoblast formation and saw
that the combination of TGFB-2, BMP-2 was successful.
• We conclude that cell line #18 is an osteoprogenitor with the
potential to assemble bone.
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Figure 4: Progentior cells induced with BMP-2 and TGFB-2 express
Osteocalcin
(A) Blue dots show DAPI staining of nuclei therefore the position of
living cells. (B) Red staining shows that IHC staining was positive for
Osteocalcin.
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